08.03.2024 – 12:34
SymbioPharm GmbH
Herborn (ots)
Anyone who has elevated cholesterol levels will not initially experience any symptoms. Too much cholesterol in the blood can cause vascular constriction and, as a result, high blood pressure. Blocked blood vessels, in turn, increase the risk of a heart attack or stroke. With SymbioLife® Cholesterol Control, SymbioPharm GmbH offers a new dietary supplement that supports normal cholesterol levels*. It contains a combination of selected lactic acid bacteria and phytosterols*.
Cholesterol is a vital building block in our cell membranes and the precursor of bile acids and certain hormones. However, if there is an excess, the cholesterol can build up on the walls of the blood vessels as plaques and thus narrow the vessels. This reduces blood circulation and high blood pressure is the result. A blockage of the vessels supplying the heart or brain can trigger a heart attack or stroke.
Our body produces most of the cholesterol itself; a maximum of a third comes from animal foods such as eggs, butter, meat and fish. Changing your diet to plant-based foods is therefore beneficial, but has a limited effect.
Lactic acid bacteria against elevated cholesterol levels
Intestinal bacteria support our digestion in many ways and have other positive effects in the body. Lactic acid bacteria in particular can bind cholesterol to their cell membrane, which is then excreted in the stool.
The special bacterium Lactobacillus plantarum LPLDL® breaks down bile acids, which our body then excretes in large numbers.(1) As a result, the liver has to produce new bile acids because we need them to digest fat. As a result, the liver removes cholesterol from the blood – the values for total cholesterol and the “bad” LDL cholesterol decrease.(1+2)
Phytosterols support normal cholesterol levels
Phytosterols are secondary plant substances and are similar in structure to cholesterol. If we absorb phytosterols, they compete with cholesterol for transport mechanisms in the intestine. The displaced cholesterol remains in the intestine and is then excreted in the stool. Although our body produces cholesterol itself, it cannot completely compensate for the inhibited absorption. This reduces the levels of LDL and total cholesterol.
“Good” and “bad” cholesterol
So that our body can transport the non-water-soluble cholesterol in the blood, it uses lipoproteins – complexes of fats and proteins that bind the cholesterol. Experts differentiate between different proportions based on their density: LDL cholesterol transports cholesterol from the liver into the body. It is considered “bad” cholesterol because high LDL levels are associated with an increased risk of cardiovascular disease. Atherosclerotic plaques in the blood vessels are made of chemically modified LDL cholesterol.
High total cholesterol also increases the risk of cardiovascular disease.
In contrast, HDL cholesterol is considered “good” cholesterol because it transports cholesterol from the organs to the liver. The liver converts cholesterol into bile acids that can be excreted.
SymbioLife® Cholesterin Control
The dietary supplement is available in two pack sizes: with 40 (PZN 18757755) and with 80 (PZN 18757761) tablets. It provides 4 billion colony-forming units (CFU) of the special lactic acid bacterial strain Lactobacillus plantarum LPLDL® and 800 mg (= 0.8 g) of phytosterols per daily dose (= 2 tablets).
Recommended dosage: Take 2 tablets per day (preferably after main meals) without chewing with a glass of water.
*Phytosterols contribute to the maintenance of normal blood cholesterol levels – with an intake of at least 0.8 g of phytosterols per day.
More at www.symbiopharm.de
Sources:
1) Costabile et al., 2017: PLoS ONE 12 (12): e0187964
2) Keleszade et al., 2022: Journal of Functional Foods 89: 104939.
About SymbioPharm GmbH
SymbioPharm GmbH is a pioneer in microbiome research and knowledge-based probiotics. As pioneers of microbiological therapy, our mission is to maintain health and cure diseases with the help of probiotic bacteria.
To this end, we research the human microbiome and develop revolutionary microbiological therapeutic approaches for intestinal and respiratory health as well as the immune system. We rely on the biological effects of natural intestinal bacteria to promote the health of our users.
The most modern processes in our biotech laboratory enable us to develop innovative pharmaceutical products, such as Symbioflor® – the first probiotic medicine in Germany. The OTC drug brand has been on the market since 1954.
SymbioPharm GmbH benefits from its own production in Germany. We work with the highest quality standards and are constantly developing new products for prophylaxis and therapy. This is how we are actively shaping the future of probiotic medicine.
In addition to our successful medicines, we already have a wide range of over 20 microbiotic nutritional supplements and cosmetics. Our scientifically innovative products are already present in 15 countries through international sales partnerships and can be purchased worldwide.
Particular attention is currently being paid to preparations with precision bacteria: They contain selected bacterial strains whose mechanism of action has been scientifically described. Bacterial substances cause a desired reaction in the human body.
Our vision is successful and well received! Around 2.5 million drops of our Symbioflor products are taken worldwide every day and thousands of our probiotic and prebiotic products are used for health and performance.
Naturally healthy through a healthy microbiome, because the health of tomorrow lies in the probiotics of today.
Press contact:
Angelika Hecht
Public Relations
SymbioPharm GmbH
On the Lüppen 10
D 35745 Herborn
Tel.: +49 (0)2772 981-350
E-Mail: [email protected]
www.symbiopharm.de
VAT ID number DE811338144
AG Wetzlar HRB 4237
Management: Dr. Ines Bohn | Tobias Brodtkorb
Follow SymbioPharm GmbH on Facebook
( and LinkedIn (
Original content from: SymbioPharm GmbH, transmitted by news aktuell